181 related articles for article (PubMed ID: 17455112)
21. Enhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from Salvia miltiorrhiza.
Yu H; Subedi RK; Nepal PR; Kim YG; Choi HK
Arch Pharm Res; 2012 Aug; 35(8):1457-64. PubMed ID: 22941489
[TBL] [Abstract][Full Text] [Related]
22. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion.
Hao H; Wang G; Cui N; Li J; Xie L; Ding Z
Planta Med; 2006 Nov; 72(14):1311-7. PubMed ID: 17024606
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Duan W; Yu XQ; Wen JY; Chowbay B; Li CG; Sheu FS; Chan E; Zhou SF
Neurosci Lett; 2007 May; 417(3):261-5. PubMed ID: 17397998
[TBL] [Abstract][Full Text] [Related]
25. [Absorption mechanism of tanshinone II A, cryptotanshinone, tanshinone I and tanshinones extract in rat small intestine in vivo].
Yan H; Wu Q; Du S; Yang Y; Zhou L; Li X
Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(21):2917-22. PubMed ID: 21322959
[TBL] [Abstract][Full Text] [Related]
26. Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a(-/-) mouse intestine.
Stephens RH; Tanianis-Hughes J; Higgs NB; Humphrey M; Warhurst G
J Pharmacol Exp Ther; 2002 Dec; 303(3):1095-101. PubMed ID: 12438532
[TBL] [Abstract][Full Text] [Related]
27. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
Hoque MT; Kis O; De Rosa MF; Bendayan R
Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
[TBL] [Abstract][Full Text] [Related]
28. Rosmarinic acid, the active component of
Li M; Yin D; Li J; Shao F; Zhang Q; Jiang Q; Zhang M; Yang Y
Pharmazie; 2020 Jan; 75(1):18-22. PubMed ID: 32033628
[No Abstract] [Full Text] [Related]
29. Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases.
Bi HC; Zuo Z; Chen X; Xu CS; Wen YY; Sun HY; Zhao LZ; Pan Y; Deng Y; Liu PQ; Gu LQ; Huang ZY; Zhou SF; Huang M
Xenobiotica; 2008 Feb; 38(2):185-222. PubMed ID: 18197559
[TBL] [Abstract][Full Text] [Related]
30. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
31. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous determination of tanshinone I, dihydrotanshinone I, tanshinone IIA and cryptotanshinone in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study of a standardized fraction of Salvia miltiorrhiza, PF2401-SF.
Park EJ; Ji HY; Kim NJ; Song WY; Kim YH; Kim YC; Sohn DH; Lee HS
Biomed Chromatogr; 2008 May; 22(5):548-55. PubMed ID: 18205136
[TBL] [Abstract][Full Text] [Related]
35. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein.
Lecoeur S; Videmann B; Mazallon M
Toxicol Lett; 2006 Mar; 161(3):200-9. PubMed ID: 16221533
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.
Zheng L; Zhu L; Zhao M; Shi J; Li Y; Yu J; Jiang H; Wu J; Tong Y; Liu Y; Hu M; Lu L; Liu Z
AAPS J; 2016 Sep; 18(5):1289-1299. PubMed ID: 27393480
[TBL] [Abstract][Full Text] [Related]
37. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
Xiao JJ; Foraker AB; Swaan PW; Liu S; Huang Y; Dai Z; Chen J; Sadée W; Byrd J; Marcucci G; Chan KK
J Pharmacol Exp Ther; 2005 Apr; 313(1):268-76. PubMed ID: 15634944
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetic interactions between the main components in the extracts of Salvia miltiorrhiza Bge. in rat].
Song M; Hang TJ; Zhang ZX
Yao Xue Xue Bao; 2007 Mar; 42(3):301-7. PubMed ID: 17520831
[TBL] [Abstract][Full Text] [Related]
39. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
BMC Med; 2004 May; 2():16. PubMed ID: 15125776
[TBL] [Abstract][Full Text] [Related]
40. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
